ABBV trailing returns
AbbVie Inc.'s 10-year annualized return is +19.1% per year (+476.6% cumulative). How AbbVie Inc. (ABBV) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through August 18, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-08-18. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +3.4% | |
| 1 week | — | +3.5% | |
| 1 month | — | +2.2% | |
| YTD | — | +15.2% | |
| 1 year | +28.3% | +28.3% | |
| 5 years | +20.8% | +157.3% | |
| 10 years | +19.1% | +476.6% | |
| Since inception (2013) | +20.4% | +1150.5% |
Growth of ABBV#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-08-18). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from ABBV's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is AbbVie Inc.'s 10-year return?
- Over the last 10 years, AbbVie Inc. (ABBV) returned about +19.1% a year annualized (+476.6% cumulative total return).
- What is AbbVie Inc.'s return since inception?
- Since 2013, AbbVie Inc. (ABBV) has compounded at about +20.4% a year — +1150.5% in total.